[HTML][HTML] Longitudinal structural cerebral changes related to core CSF biomarkers in preclinical Alzheimer's disease: A study of two independent datasets

C Falcon, A Tucholka, GC Monté-Rubio… - NeuroImage: Clinical, 2018 - Elsevier
Alzheimer's disease (AD) is characterized by an accumulation of β-amyloid (Aβ 42)
accompanied by brain atrophy and cognitive decline. Several recent studies have shown …

Longitudinal structural cerebral changes related to core CSF biomarkers in preclinical Alzheimer's disease: A study of two independent datasets

C Falcon, A Tucholka, GC Monté-Rubio… - NeuroImage …, 2018 - pubmed.ncbi.nlm.nih.gov
Alzheimer's disease (AD) is characterized by an accumulation of β-amyloid (Aβ 42)
accompanied by brain atrophy and cognitive decline. Several recent studies have shown …

Longitudinal structural cerebral changes related to core CSF biomarkers in preclinical Alzheimer's disease: A study of two independent datasets.

C Falcon, A Tucholka, GC Monté-Rubio… - NeuroImage …, 2018 - europepmc.org
Alzheimer's disease (AD) is characterized by an accumulation of β-amyloid (Aβ 42)
accompanied by brain atrophy and cognitive decline. Several recent studies have shown …

[HTML][HTML] Longitudinal structural cerebral changes related to core CSF biomarkers in preclinical Alzheimer's disease: A study of two independent datasets

C Falcon, A Tucholka, GC Monté-Rubio… - NeuroImage …, 2018 - ncbi.nlm.nih.gov
Alzheimer's disease (AD) is characterized by an accumulation of β-amyloid (Aβ 42)
accompanied by brain atrophy and cognitive decline. Several recent studies have shown …

Longitudinal structural cerebral changes related to core CSF biomarkers in preclinical Alzheimer's disease: A study of two independent datasets.

C Falcon, A Tucholka, GC Monté-Rubio… - NeuroImage …, 2018 - europepmc.org
Alzheimer's disease (AD) is characterized by an accumulation of β-amyloid (Aβ 42)
accompanied by brain atrophy and cognitive decline. Several recent studies have shown …